Evidence that Plasmid-Borne Botulinum Neurotoxin Type B Genes Are Widespread among Clostridium botulinum Serotype B Strains by Franciosa, Giovanna et al.
Evidence that Plasmid-Borne Botulinum Neurotoxin Type
B Genes Are Widespread among Clostridium botulinum
Serotype B Strains
Giovanna Franciosa*, Antonella Maugliani, Concetta Scalfaro, Paolo Aureli
Department of Food Safety and Veterinary Public Health, Unit of Microorganisms and Food Technologies, Istituto Superiore di Sanita `, Rome, Italy
Abstract
Background: Plasmids that encode certain subtypes of the botulinum neurotoxin type B have recently been detected in
some Clostridium botulinum strains. The objective of the present study was to investigate the frequency with which plasmid
carriage of the botulinum neurotoxin type B gene (bont/B) occurs in strains of C. botulinum type B, Ab, and A(B), and
whether plasmid carriage is bont/B subtype-related.
Methodology/Principal Findings: PCR-Restriction fragment length polymorphism was employed to identify subtypes of the
bont/B gene. Pulsed-field gel electrophoresis and Southern blot hybridization with specific probes were performed to
analyze the genomic location of the bont/B subtype genes. All five known bont/B subtype genes were detected among the
strains; the most frequently detected subtype genes were bont/B1 and /B2. Surprisingly, the bont/B subtype gene was
shown to be plasmid-borne in .50% of the total strains. The same bont/B subtype gene was associated with the
chromosome in some strains, whereas it was associated with a plasmid in others. All five known bont/B subtype genes were
in some cases found to reside on plasmids, though with varying frequency (e.g., most of the bont/B1 subtype genes were
located on plasmids, whereas all but one of the bont/B2 subtypes were chromosomally-located). Three bivalent isolates
carried both bont/A and /B genes on the same plasmid. The plasmids carrying the bont gene were five different sizes,
ranging from ,55 kb to ,245 kb.
Conclusions/Significance: The unexpected finding of the widespread distribution of plasmids harboring the bont/B gene
among C. botulinum serotype B strains provides a chance to examine their contribution to the dissemination of the bont
genes among heterogeneous clostridia, with potential implications on issues related to pathogenesis and food safety.
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Introduction
Botulinum neurotoxins (BoNTs) are zinc-dependent metallo-
proteases that inhibit the release of the neurotransmitter
acetylcholine from peripheral cholinergic synapses. Through this
mechanism of action, they can cause the flaccid paralysis of
botulism in humans exposed through foodborne intoxication or
intestinal and wound toxemias, thus representing a serious
pathogenic and biodefense threat. However, when properly
administered they can also provide therapeutic and cosmetic
benefits in conditions characterized by excessive cholinergic
activity [1].
Seven structurally similar but serologically distinct BoNT
variants (A to G) have been identified: of these, BoNT/A and /
B are the most frequent causes of human botulism worldwide, and
both are used as therapy against a wide variety of involuntary
muscle disorders [1,2]. Recently, comparison of the available
BoNT gene and protein sequences has revealed that a certain
variability exists within individual BoNT serotypes [3,4]. In
particular, for six of the seven BoNT serotypes (all but serotype
G), subtypes that diverge at the amino-acid level by at least 2.6%
have been defined: for example, BoNT/A has four distinct
subtypes which differ from each other at the amino-acid level by
up to 16% (BoNT/A1, /A2, /A3, and /A4), and BoNT/B has five
subtypes, differing by up to 6% (BoNT/B1, /B2, /B3, non-
proteolytic B, and bivalent B) [4].
All BoNT serotypes and subtypes are encoded by specific bont
genes that may reside in the genome of six heterogeneous
clostridia groups, comprising at least four distinct species (i.e.,
Clostridium botulinum, C. argentinense, C. barati, and C. butyricum) [2].
The bont/C and /D genes are located on distinct bacteriophages
[5,6], and the bont/G gene is located on a plasmid [7,8], whereas
the bont/A, /B, /E and /F genes have long been assumed to be
chromosomally located. The genome sequencing of the BoNT/
A1-producing C. botulinum strain Hall (ATCC 3502) confirmed the
chromosomal location of the bont/A1 subtype gene [9]. However,
unexpectedly, the bont/A3 and bont/A4 subtype genes of the only
two BoNT/A3- and /A4-producing strains identified to date (i.e.,
Loch Maree and 657) were recently shown to reside on large
molecular weight plasmids (,267 kb and 270 kb, respectively)
PLoS ONE | www.plosone.org 1 March 2009 | Volume 4 | Issue 3 | e4829[10]. Strain 657 forms greater amounts of bivalent BoNT/B than
of BoNT/A4 and is thus regarded as C. botulinum type Ba [11]: its
bivalent bont/B subtype gene was shown to reside on the same
270 kb plasmid that carries the bont/A4 subtype gene [10].
Nucleotide sequencing confirmed these results and also showed
that the bont/B1 subtype gene of the C. botulinum strain Okra was
located on a ,149 kb plasmid; the plasmids described in strains
Loch Maree, 657, and Okra have been designated as ‘‘pCLK’’,
‘‘pCLJ’’, and ‘‘pCLD’’, respectively (GenBank Accession numbers
CP000940 and CP000963) [12]. A ,48 kb plasmid (pCLL) from
strain Eklund 17B (ATCC 25765) containing the non-proteolytic
bont/B subtype gene has been sequenced by the Los Alamos
National Laboratory of the United States (GenBank Accession
number CP001057), but has not been published to date.
These findings challenge the previous assumption of a
chromosomal location of the bont/A and /B genes and raise
questions as to whether plasmid-borne bont genes are rare or
widespread among botulinum neurotoxigenic clostridia.
BoNT/B is the most frequent cause of human botulism in
Europe (including Italy) and the second leading cause of botulism
in North America [13,14]. The purpose of the present study was to
evaluate the genomic location of subtypes of the bont/B gene in a
panel of C. botulinum strains of different origins. We also
investigated the association between certain subtypes of the bont/
B gene and plasmid carriage. The results are the first evidence that
all five known bont/B subtype genes can reside on plasmids that
vary considerably in size, and they clearly indicate that plasmid-
borne bont/B genes are more widespread among C. botulinum
serotype B isolates than previously known.
Results
PCR-Restriction Fragment Length Polymorphism (RFLP)
subtyping of the bont/B gene
Based on the alignment of sequences of the bont/B gene
(3876 bp) present in the GenBank database, the region encom-
passing nucleotides 920 to 3727 was selected for PCR amplifica-
tion because it has shown a certain degree of nucleotide
polymorphism. This region mainly encodes the transmembrane
and receptor binding domains of the neurotoxin, where most of
the amino-acid differences among the BoNT/B subtypes have
been reported [3]. Analysis of the 2807 bp region from the five
distinct bont/B subtypes using the restriction mapper program
Webcutter 2.0 (http://rna.lundberg.gu.se/cutter2/) allowed for
the selection of four endonucleases (HindIII, SacI, BamHI and
EcoRV) that were likely to generate distinct RFLP patterns among
the different bont/B subtypes.
This approach was tested with 4 C. botulinum strains whose bont/
B subtype was known and which were included in these
experiments as references (Table 1): specifically, CDC-1758 for
bont/B1 (GenBank Accession number: EF033127); CDC-1828 for
bont/B2 (GenBank Accession number: EF051571); CDC-4848
(ATCC 25765) for non-proteolytic bont/B (GenBank Accession
number: X71343); and CDC-1436 for bivalent bont/B (GenBank
Accession number: AF295926) [4]. Once the PCR products from
these strains were cut with the four restriction enzymes, each bont/
B subtype was characterized by a specific restriction profile that
was consistent with the one expected from the theoretical analysis
(Figure 1). We lacked a reference for the bont/B3 subtype because
the single C. botulinum strain that has been shown to harbor the
bont/B3 subtype (strain CDC-795, GenBank Accession number:
EF028400) [4] was not in our panel of strains. However, the
theoretical restriction map analysis revealed an EcoRV restriction
site at position 1828 of the 2807 bp region of the bont/B3 gene,
which was absent from the analogous region of the other bont/B
subtypes. It was therefore deduced that the PCR-RFLP strategy
could be used for subtyping the bont/B gene.
All five bont/B PCR-RFLP subtypes were detected among the
63 C. botulinum strains that were tested (Table 2). Bont/B1 and /B2
were the most frequent PCR-RFLP subtypes and were identified
in, respectively, 23 (36.5%) and 22 (34.9%) strains of the total 63
tested. Bont/B1 predominated among the US strains (22/43
strains), whereas bont/B2 was predominant among the Italian
strains (18/20 strains). To date, the bivalent bont/B subtype has
only been described in C. botulinum bivalent strains, which are
designated as ‘‘bivalent’’ because they harbor two distinct bont
genes [3,4]. In this study the bivalent bont/B PCR-RFLP subtype
was identified in 7 of the 9 bivalent C. botulinum strains tested: of
these, 5 were C. botulinum type A(B) strains which only produce
BoNT/A because their bont/B gene remains unexpressed [15], and
2 were C. botulinum type Ab strains which concomitantly produces
both BoNT/A and /B, the latter in minor amounts [16].
Furthermore, the bivalent bont/B PCR-RFLP subtype was
atypically detected in 7 C. botulinum type B strains that were non-
bivalent, that is, negative for bont genes other than B when tested
by PCR (data not shown). Hence, a total of 14 strains (22.2% of
the 63 tested) displayed the bivalent bont/B PCR-RFLP subtype.
Surprisingly, the remaining two bivalent C. botulinum type Ab
strains (ISS-87 and ISS-92), both from Italy, displayed a bont/B1
and a bont/B3 PCR-RFLP subtype, respectively, rather than the
expected bivalent bont/B subtype: since both strains had previously
been shown to contain a bont/A2 gene [17], they represent two
novel A2/B1 and A2/B3 bivalent variants. The bont/B3 PCR-
RFLP subtype was detected in an additional C. botulinum type B
strain, whereas the non-proteolytic bont/B PCR-RFLP subtype
was only identified in the reference strain and one additional
nonproteolytic C. botulinum type B strain.
Genomic localization of the bont/B and /A subtype genes
Previous studies have demonstrated that Southern blot analysis
of pulsed-field gels containing undigested genomic DNA from
bacterial cells can be used to establish whether a certain gene is
chromosomally or extra-chromosomally located [18,19]. The
same strategy, based on pulsed-field gel electrophoresis (PFGE)
and subsequent hybridization with bont/A and /B specific gene
probes, has also been applied to show plasmid carriage of the bont/
A3, /A4, and bivalent bont/B subtype genes [10]. We used this
PFGE Southern blot approach to define the genomic location of
the bont/B genes for the total 63 C. botulinum strains included in this
study (Table 1); the genomic location of the bont/A gene in the 4
type Ab and 5 type A(B) C. botulinum strains was analyzed as well.
Three of the 63 C. botulinum strains (CDC-7827, displaying the
bont/B1 PCR-RFLP subtype; ISS-310, displaying the bont/B2
PCR-RFLP subtype; and CDC-2312, displaying the bivalent bont/
B PCR-RFLP subtype) repeatedly produced DNA smears after
PFGE, presumably due to enhanced DNAse activity: consequent-
ly, they were not suitable for the subsequent hybridization
experiments, and the genomic location of their bont genes could
not be determined by this technique.
The bont/B probe hybridized to the chromosomal band of 28 C.
botulinum strains (47% of the total 60 PFGE-typeable strains tested).
In the remaining 32 C. botulinum strains (53%), the bont/B probe
hybridized to an extra-chromosomal band (Table 3). In particular,
extra-chromosomal location was found for: 21/22 (95%) of the
bont/B1 PCR-RFLP subtypes; 2/2 (100%) non-proteolytic bont/B
subytpes; 7/13 (54%) bivalent bont/B subtypes, of which 6
atypically detected in non-bivalent C. botulinum strains (Table 1);
1/2 (50%) bont/B3 subtypes, the latter atypically detected in a
Plasmid-Borne Bont/B Genes
PLoS ONE | www.plosone.org 2 March 2009 | Volume 4 | Issue 3 | e4829Table 1. C. botulinum strains analyzed in this study, and genomic location of their bont/B and /A PCR-RFLP subtype genes.
Strain no
1 Toxin type State Year Source
2 bont/B subtype
3
bont/B genomic
location
bont/A
subtype
bont/A genomic
location
plasmid
size (kb)
4
CDC-555 B OH 1976 corn B1 plasmid 245
CDC-620 B PA 1976 IB B1 plasmid 245
CDC-628 B CT 1976 uB B1 plasmid 217
CDC-661 B TN 1976 IB B2 chromosome
CDC-668 B TN 1976 IB B1 plasmid 245
CDC-706
5 B AK 1976 salmon Bnp plasmid 55
CDC-816 B MI 1977 peppers B3 chromosome
CDC-1588 B AZ 1977 IB Bbv plasmid 170
CDC-1632 B PA 1977 IB B1 chromosome
CDC-1758 B OR 1977 IB B1 plasmid 245
CDC-1828 B MO 1978 IB B2 chromosome
CDC-1852 B CO 1978 FB Bbv plasmid 245
CDC-1872 B MD 1978 IB B1 plasmid 139
CDC-2064 B PA 1978 IB B1 plasmid 139
CDC-2094 B MA 1978 AB B1 plasmid 245
CDC-2113 B NJ 1978 IB B1 plasmid 245
CDC-2292 B PA 1978 IB B1 plasmid 245
CDC-2306 B NJ 1978 IB B1 plasmid 245
CDC-2312 B PA 1978 IB Bbv n.d.
6
CDC-2329 B DE 1978 IB B1 plasmid 245
CDC-2358 B MA 1978 uB Bbv plasmid 245
CDC-2586 B KY 1979 IB B2 chromosome
CDC-2589 B KY 1979 FB B1 plasmid 139
CDC-2593 B KY 1979 AB B1 plasmid 245
CDC-2746 B NY 1979 IB B1 plasmid 245
CDC-2978 B CO 1979 IB Bbv plasmid 170
CDC-4848
5 B ATCC 25765 Bnp plasmid 55
CDC-5078 B HI 1983 IB Bbv plasmid 245
CDC-5153 B IN 1984 IB B1 plasmid 139
CDC-5168 B HI 1984 IB Bbv plasmid 245
CDC-5250 B LA 1984 IB B1 plasmid 245
CDC-5281 B OK 1984 IB B2 chromosome
CDC-5323 B DE 1985 IB B1 plasmid 245
CDC-7699 B LA 1990 FB B1 plasmid 245
CDC-7827 B NV 1991 IB B1 n.d.
6 245
MDb02 B - - - B1 plasmid 245
ISS-BC1 B I 2000 olives B2 chromosome
ISS-BC2 B I 2000 olives B2 chromosome
ISS-BC3 B I 2001 truffles B2 chromosome
ISS-251 B I 2003 chickpea B2 chromosome
ISS-257 B I 2002 FB B2 chromosome
ISS-267 B I 2003 IB B2 chromosome
ISS-274 B I 2004 FB B2 chromosome
ISS-276 B I 2002 honey B2 chromosome
ISS-306 B I 2004 FB B2 chromosome
ISS-310 B I 2004 FB B2 n.d.
6
ISS-331 B I 2004 IB B2 chromosome
ISS-333 B I 2004 FB B2 plasmid 245
Plasmid-Borne Bont/B Genes
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B2 subtypes.
When the Southern blots of the PFGE gels containing the
genomic DNA from the bivalent C. botulinum strains included in this
study were stripped and rehybridized with a bont/A specific gene
probe, a hybridization signal was observed at the same blot location
that reacted with the bont/B specific gene probe, indicating that the
bont/A and /B genes share the same genomic location in these
strains. Specifically, both bont/A and /B probes hybridized to the
chromosomal band of 6 bivalent C. botulinum strains, including all 5
C. botulinum type A(B) strains and 1 of the 4 C. botulinum type Ab
strains (CDC-588): all 6 strains exhibited the bivalent bont/B PCR-
RFLP subtype and had previously been shown to possess the bont/
A1 subtype[17,20]. In the remaining 3 bivalent C. botulinum type Ab
strains (CDC-1436, ISS-87, and ISS-92), both bont/A and /B
probes hybridized to the same extra-chromosomal blot location: the
3 strains exhibited bont/B1, /B3, and bivalent/B PCR-RFLP
subtypes, respectively, and had previously been shown to possess the
bont/A2 subtype [17,20] (Table 1).
Figure 2 shows a PFGE gel stained with ethidium bromide and
its Southern blot membrane after hybridization with a non-
radioactive bont/B gene probe.
Table 1. cont.
Strain no
1 Toxin type State Year Source
2 bont/B subtype
3
bont/B genomic
location
bont/A
subtype
bont/A genomic
location
plasmid
size (kb)
4
ISS-338 B I 2002 honey B2 chromosome
ISS-342 B I 2004 tuna fish B2 chromosome
ISS-360 B I 2005 peppers B2 chromosome
ISS-372 B I 2005 beans B2 chromosome
ISS-378 B I 2006 mushrooms B2 chromosome
ISS-388 B I 2006 FB B2 chromosome
CDC-588 Ab OH 1976 FB Bbv chromosome A1 chromosome
CDC-1436 Ab UT 1977 IB Bbv plasmid A2 plasmid 245
ISS-87 Ab I 1995 FB B3 plasmid A2 plasmid 245
ISS-92 Ab I 1993 FB B1 plasmid A2 plasmid 245
CDC-1634 A(B) PA 1977 IB Bbv chromosome A1 chromosome
CDC-1727 A(B) AK 1977 whale oil Bbv chromosome A1 chromosome
CDC-1807 A(B) CO 1977 beans and franks Bbv chromosome A1 chromosome
CDC-4893 A(B) IL 1983 FB Bbv chromosome A1 chromosome
CDC-5277 A(B) WV 1984 IB Bbv chromosome A1 chromosome
1CDC (Centers for Disease Control and Prevention, USA); ISS (Istituto Superiore di Sanita `, Italy).
2IB (infant botulism); FB (foodborne botulism); AB (animal botulism); uB (unknown botulism).
3Bnp (non-proteolytic B); Bbv (bivalent B).
4The size of the closest molecular standard bands are indicated.
5Non-proteolytic C. botulinum.
6n.d.=Not determined, because of DNA degradation.
doi:10.1371/journal.pone.0004829.t001
Figure 1. BamHI, HindIII, SacI and EcoRV restrictions of the bont/B PCR products obtained from strains CDC-1758 (lanes 1, 5, 9, 14);
CDC-1828 (lanes 2, 6, 10, 15); CDC-1436 (lanes 3, 7, 11, 16); CDC-4848 (lanes 4, 8, 12); CDC-816 (lane 13). M.S. (Molecular standard, 1 kb
Promega).
doi:10.1371/journal.pone.0004829.g001
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chromosomal bands
The PFGE Southern blot assay can also be used to estimate the
size of extra-chromosomal hybridization bands, when present;
however, large circular DNA molecules can exhibit anomalous
migration during PFGE [21,22]. As shown in Figure 3a, the DNA
preparations from several C. botulinum isolates displayed double
bands after hybridization with the bont/B gene probe: this could
indicate either that these isolates carry multiple copies of the bont/
B gene on two distinct extra-chromosomal elements of different
sizes or that the same extra-chromosomal element harboring the
bont/B gene exists as variable forms whose mobility differs under
PFGE conditions. The latter hypothesis is consistent with the
diverse mobility of the isoforms of large (.100 kb) circular
plasmids: i) open circular forms, which remain trapped in the
sample wells of pulsed-field gels; ii) closed supercoiled forms, which
move slowly under PFGE conditions; and iii) linear forms, which
migrate at rates that allow the size of the plasmids to be accurately
determined [22]. Based on these considerations, the double extra-
chromosomal bands that we observed in some DNA samples
might correspond to the linear and supercoiled forms of the same
plasmids. To test this hypothesis, the PFGE plugs were treated
with S1 nuclease, which enzymatically converts all plasmid forms
into linear forms [22]. The S1 nuclease treatment caused the
disappearance of the slower of the two bands present in the DNA
samples, indicating that this band was probably the supercoiled
plasmid; the mobility of the faster band was not affected by S1
nuclease treatment, which is consistent with the behavior expected
for the linear plasmid [22]. Whether or not linear and supercoiled
plasmid forms are present depends on the age of the culture [22],
which is consistent with the appearance of the double hybridiza-
tion bands in some, but not all, of our DNA samples: in fact, the
DNA preparations that we used were obtained from bacteria
collected from overnight cultures, whose growth phases were not
uniform (see the Materials and Methods section). Other DNA
samples displayed single extra-chromosomal bands after hybrid-
ization with the bont/B gene, which presumably corresponded to
the linear plasmid forms; indeed, their mobility did not change
after S1 nuclease treatment.
As illustrated in Figure 3b, PFGE resolved at least five
differently sized bont/B-carrying plasmids among the 32 C.
botulinum isolates. They ranged from ,55 kb to ,245 kb, as
determined by comparison with a molecular standard (DNA
isolated from Salmonella enterica serotype Braenderup strain H9812
and restricted with XbaI) [23]. Specifically, a plasmid greater than
the 245 kb band of the molecular size marker was detected in 23
C. botulinum strains (72% of the 32 strains harboring a plasmid-
borne bont/B gene). Of these, 16 displayed the bont/B1 PCR-RFLP
subtype, 5 displayed the bivalent bont/B PCR-RFLP subtype, and
2 displayed the bont/B2 and bont/B3 PCR-RFLP subtypes
(Table 4). A plasmid in line with the 139 kb band of the molecular
standard was observed in 4/32 (12.5%) C. botulinum strains, all of
which exhibited the bont/B1 PCR-RFLP subtype. Furthermore,
plasmids close in size to the 170 kb and 55 kb bands of the
Table 3. Plasmid-borne bont/B PCR-RFLP subtype genes
among C. botulinum strains.
bont/B PCR-RFLP
subtype
No. of PFGE-typeable
strains (n=60)
Plasmid carriage (%)
(n=32)
B1 22 21 (95%)
B2 21 1 (5%)
B3 2 1 (50%)
bivalent B 13 7 (54%)
nonproteolytic B 2 2 (100%)
doi:10.1371/journal.pone.0004829.t003
Figure 2. PFGE gel (a) and Southern blot membrane after
hybridization with a bont/B gene probe (b). Strains: ISS-274 (lanes
1, 8); CDC-2589 (lanes 2, 9); CDC-2306 (lanes 3, 10); CDC-1872 (lanes 4,
11); CDC-5250 (lanes 5, 12); ISS-BC2 (lanes 6, 13); CDC-5323 (lanes 7, 14).
M.S. (Molecular standard: DNA isolated from Salmonella enterica
serotype Braenderup strain H9812 and restricted with XbaI) [23].
doi:10.1371/journal.pone.0004829.g002
Table 2. Distribution of bont/B PCR-RFLP subtype genes among 63 C. botulinum strains.
bont/B PCR-RFLP subtype No. (%) of strains No. of C. botulinum strains (total)
Type B (54) Type Ab (4) Type A(B) (5)
Italy (18) USA (36) Italy (2) USA (2) Italy (0) USA (5)
B1 23 (36.5) 22 1
B2 22 (34.9) 18 4
B3 2 (3.2) 1 1
bivalent B 14 (22.2) 7 2 5
nonproteolytic B 2 (3.2) 2
doi:10.1371/journal.pone.0004829.t002
Plasmid-Borne Bont/B Genes
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both ,170 kb plasmids carried the bivalent bont/B PCR-RFLP
subtype, whereas both ,55 kb plasmids carried the non-
proteolytic bont/B PCR-RFLP subtype. Finally, a unique plasmid
of approximately 217 kb was detected in a single strain displaying
the bont/B1 PCR-RFLP subtype. The plasmids harboring both
bont/A and /B genes that were detected in 3 bivalent C. botulinum
strains were .245 kb.
Discussion
Subtype diversity within BoNT serotypes can significantly
impact their receptor binding, target affinity and antibody
recognition; the latter issue may be critical for the development
of effective neutralizing antibodies [3]. However, little is known
about the distribution of the BoNT subtypes and their encoding
genes among C. botulinum strains with different origins. We
previously analyzed the bont/A gene of a set of C. botulinum strains
using a PCR-RFLP approach [17]: although this method can only
detect a few single nucleotide polymorphisms that are recognized
by specific restriction enzymes, it correctly identified the bont/A
subtype genes, as subsequently shown by the complete nucleotide
sequencing of some of those genes [24,25]. In the current study,
we adopted a similar PCR-RFLP approach for subtyping the bont/
B gene in a panel of C. botulinum strains from different origins
(clinical forms of botulism and foods), countries, and periods. Our
results revealed that the bont/B2 PCR-RFLP subtype was more
prevalent among C. botulinum strains from Italy, whereas the bont/
B1 PCR-RFLP subtype prevailed among strains from the US,
confirming earlier suggestions by Hill et al. [4]. A similar
geographic distribution has been found for bont/A subtypes, with
bont/A2 more prevalent in Italy and bont/A1 more prevalent in the
US [17]. These results could reflect a variation in the evolutionary
history of both bont/A and /B subtypes. Furthermore, no
correlation was observed between any specific bont/B subtype
and the clinical or food source of the strains or the period in which
the strains were isolated, as previously shown for bont/A subtypes
[17].
Unexpectedly, we found that the bivalent bont/B PCR-RFLP
subtype was not restricted to the bivalent C. botulinum strains and
Figure 3. Southern blot membrane before (a) and after (b) S1 nuclease treatment. Strains: CDC-MDb2 (lanes 1, 11); CDC-1758 (lanes 2, 12);
CDC-5078 (lanes 3, 13); CDC-1852 (lanes 4, 14); CDC-1872 (lanes 5, 15); CDC-628 (lanes 6, 16); CDC-1588 (lanes 7, 17); CDC-2978 (lanes 8, 18); CDC-706
(lanes 9, 19); CDC-4848 (lanes 10, 20). M.S. (Molecular standard: DNA isolated from Salmonella enterica serotype Braenderup strain H9812 and
restricted with XbaI) [23].
doi:10.1371/journal.pone.0004829.g003
Table 4. Molecular size of the plasmids carrying the different bont/B subtype genes.
Plasmid Size (kb)
a bont/B1 bont/B2 bont/B3 bivalent bont/B Nonproteolytic bont/B
,245 16 1 1 5 2
,217 1 222 2
,170 2222 2
,139 4 222 2
,55 2222 2
aThe plasmid sizes were deduced by comparison with a molecular standard [23].
Slight differences between the sizes of plasmids included in the same group were observed.
doi:10.1371/journal.pone.0004829.t004
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that two bivalent C. botulinum type Ab strains exhibited the bont/B1
and /B3 PCR-RFLP subtypes. These results could indicate that
the bont/B genes of these peculiar C. botulinum strains could be
previously unrecognized subtype genes, although this would need
to be confirmed with sequencing. Alternatively, the finding that
some C. botulinum strains display bont/B subtypes other than the
expected ones could be indicative of mobilization of the bont/B
gene among strains at some point during evolution. Circumstantial
evidence that the bont/B gene is mobile and might have been
transferred among progenitor strains already exists, in particular: i)
BoNT/B can be formed by C. botulinum strains of different
clostridia groups [2]; ii) BoNT/B is produced along with another
BoNT type by some C. botulinum strains, such as those of type Ab,
Ba, and Bf [16]; iii) a silent bont/B gene is present in the genome of
C. botulinum type A(B) strains [15]; and iv) toxigenic C. botulinum
type B and its non-toxigenic derivatives have been isolated from
the same samples [26]. Although there is no direct evidence of the
mobilization of the bont/B gene, the recent demonstrations that the
gene is plasmid-encoded in certain C. botulinum strains further
support this hypothesis: indeed, plasmids may play an important
role in mediating genetic transfer within and among bacterial
genomes [27].
With regard to the genomic location of the bont/B1, /B3 and
bivalent /B subtype genes atypically detected in the C. botulinum
strains mentioned above, our results showed that the bont/B genes
were extra-chromosomally located in all of these strains, though
for one strain the bivalent bont/B subtype gene could not be
localized because of consistent DNA degradation. Analysis of the
genomic location of the bont/B genes was then extended to all C.
botulinum strains included in this study: surprisingly, extra-
chromosomal elements carrying the bont/B gene were detected
in most (53%), with no apparent relationship with their origin.
We assumed that the bont/B-carrying extra-chromosomal
elements were circular plasmids, based on the agreement between
their PFGE migration and the mobility behavior predicted for the
supercoiled and linear forms of circular plasmids [22]. Further-
more, some of the extra-chromosomal elements were similar in
size to those of the bont/B-encoding plasmids determined to date
[i.e., 270 kb for pCLJ of strain 657, 149 kb for pCLD of strain
Okra [12], and 48 kb for pCLL of strain Eklund 17B (GenBank
Accession number CP001057)], though two previously unreported
sizes were also revealed in this study. However, we predicted the
plasmid sizes by comparison with a molecular standard, whereas
an accurate size determination would require the complete
nucleotide sequencing of the plasmids.
Our results indicate that all bont/B subtypes can be located on
plasmids and that a C. botulinum strain can only carry bont/B
plasmids of a single size. Specifically, of the bont/B plasmids
identified for 32 C. botulinum strains, 24 were greater than 200 kb,
and the remaining 8 ranged from approximately ,55 kb to
,170 kb: assuming that the C. botulinum chromosome is about
3.9 Mb [9], such plasmids would constitute a variable proportion
(from 0.1% to 6%) of the genomes of the strains harboring them.
The largest plasmids (,245 kb) were associated with all bont/B
subtypes, except for the non-proteolytic bont/B subtypes, which
were only associated with the smallest plasmids (,55 kb). Notably,
one of the non-proteolytic bont/B subtypes belonged to strain
CDC-4848 (or ATCC 25765), which was found to correspond to
strain Eklund 17B: this strain has plasmid sequence of ,48 kb
(GenBank Accession number CP001057), which is similar to the
,55 kb in our study. The intermediate-sized plasmids detected in
the present study were associated with either the bont/B1 or the
bivalent bont/B subtypes, suggesting that both subtypes can reside
on plasmids of different sizes. For the strains whose bont/B gene
was plasmid-borne, no chromosomal band hybridized with the
bont/B gene probe, indicating that the plasmids did not integrate
with the chromosome.
Remarkably, 95% of the bont/B1 subtypes resided on plasmids,
whereas the same percentage of the bont/B2 subtypes resided on
the chromosome. Although the biological significance of this
finding is unclear, it supports the hypothesis of diverse evolution-
ary pathways for the bont/B1 and /B2 subtypes, as hypothesized
above based on their geographic separation.
For three of the nine bivalent C. botulinum strains (all three of
type Ab), the bont/A and /B genes were located on the same
plasmid, whose size was similar to that of plasmid pCLJ (270 kb) of
the bivalent C. botulinum type Ba strain 657 [10,12]. However, for
the other 6 bivalent C. botulinum strains [one of type Ab and 5 of
type A(B)], the bont/A and /B genes were located in the
chromosome. The finding that the bont/A and /B genes share
the same genomic location (whether it was the chromosome or the
plasmid) suggests that they are structurally linked. The specific
location could be related to the bont/A subtype: in fact, all three of
the strains showing plasmid location of the genes had bont/A2 and
all 6 of the bivalent strains with chromosome location had bont/A1
[17,20]. However, this hypothesis would need to be tested with
more bivalent strains.
To determine the reasons for which the genomic location of the
bont/A and /B genes varies among the different C. botulinum strains,
the bont plasmids identified in the present study will need to be
characterized at the sequence level. Partial mobile-enabling
sequences, such as insertion sequences (IS), have been detected
downstream of the bont/B and /A genes in plasmids pCLJ, pCLD
and pCLK; when chromosomal, the bont genes are flanked by both
upstream and downstream IS-like elements, which might be
indicative of transposon integration [12]. The association between
remnants of IS elements and the bont/A and /B genes suggests that
these genes could have been mobilized and stably inserted into the
chromosome or plasmid, depending on the recipient Clostridium
ancestor strain [28]. The same mechanism might have contributed
to the dissemination of the bont genes among heterogeneous groups
of clostridia; in this respect, the ability of the BoNT-encoding
plasmids to undergo conjugation or other types of genetic transfer
should also be investigated.
Notably, many similarities have previously been reported
among the BoNT/B of C. botulinum, the BoNT/G of C. argentinense,
and the tetanus neurotoxin (TeNT) of C. tetani, which is also
plasmid-encoded [29]: in particular, these neurotoxins have a high
nucleotide and amino-acid sequence homology [4,30], and they
cleave the same presynaptic membrane protein synaptobrevin,
though at different peptide bonds [1]. Furthermore, BoNT/B and
/G recognize the same neuronal receptors [31,32]. The finding
that the bont/B gene can be plasmid-borne, like the bont/G and tent
genes, strongly supports the hypothesis that they descend from a
common ancestor.
A future challenge will be to determine whether the BoNT-
encoding plasmids play a role in the development and/or
flexibility of C. botulinum, thus potentially increasing its adaptability
to certain niches, such as specific environments and food matrixes,
and ultimately contributing to the disease of botulism.
Materials and Methods
Clostridia strains and culture conditions
A total of 63 C. botulinum strains were used in this study (Table 1).
Of these, 20 were from the culture collection of the National
Reference Center for Botulism, Istituto Superiore di Sanita ` (ISS),
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remaining 43 strains, isolated in the United States from 1976 to
1990, were generously provided by Charles Hatheway of the
Botulism Laboratory, Centers for Disease Control and Prevention
(CDC), Atlanta, GA.
Forty-six strains were of clinical origin, specifically, 45 were
from distinct cases of human botulism and 1 from animal
botulism; 1 strain (ATCC 25765) was from a marine sediment
of the West Coast of the US; 1 strain was of unknown origin; and
the remaining 14 strains were from different types of foods.
Fifty-four strains were C. botulinum type B (i.e., they produced
BoNT/B and were positive for the bont/B gene when tested by
PCR)[15]; 9 other strains had been shown to contain, in additionto
the bont/A gene, a bont/B gene in their genome, which was either
silent [C. botulinum A(B)] (CDC-1634, -4893, -5277, -1807, and
-1727) or expressed [C. botulinumAb] (CDC-588,-1436, ISS-87, and
-92)[15,17].Clostridia stockcultureswerechecked forpurityonegg
yolk agar (EYA) plates (Oxoid, Basingstoke, England). Single
colonies were transferred from the plates to 10 ml of TPGY broth
(5% Trypticase, 0.5% peptone, 0.4% glucose, 2% yeast exctract,
1% L-cysteine hydrocloride monohydrate) and grown overnight at
37uC, under anaerobiosis (GasPack jars, Oxoid).
For the PCR experiments, 1 ml from each overnight broth-
culture was centrifuged and washed with 1XTE buffer (10 mM
Tris, pH 7.4, 1 mM EDTA); the pellets were re-suspended in 1 ml
of sterile distilled water, and 5 ml of the cell suspensions was used
as DNA template in each PCR reaction mixture. Nine milliliters of
the overnight TPGY broth-cultures was used for the PFGE
experiments.
PCR restriction fragment length polymorphism (RFLP)
subtyping of the bont/B gene
Primers BS1 (59 AGTTTGCATATCAGATCCTAA 39) and
BS2 (59 AACGATGAATACCAATCAATCC 39) were selected in
conserved regions of the aligned bont/B gene sequences available
from the GenBank database, to generate a PCR product
encompassing nucleotides 920 to 3727. PCR products were
amplified in a programmable thermal cycler (M.J. Research,
model PTC100, Waltham, MA) using the Expand High Fidelity
PCR System (Roche Diagnostics, Penzberg, Germany) according
to the manufacturer’s instructions with the following amplification
parameters: 1 cycle of 2 min at 94uC; 30 cycles consisting of 15 sec
at 94uC, 30 sec at 50uC, 4 min at 68uC with 5 sec of increment/
cycle; and a final cycle at 68uC for 7 min. The PCR products were
resolved by TAE gel electrophoresis, purified by a DNA gel
extraction kit (Montage, Millipore Corporation, Bedford, MA,
USA), and digested separately with 10 units of BamHI, HindIII,
SacI and EcoRV (New England Biolabs, Ipswich, MA). All
restrictions were performed at least twice.
Pulsed-field gel electrophoresis (PFGE) and S1 nuclease
treatment of plugs
Agarose plugs containing the genomic DNA from the bacterial
cultures were prepared as previously described [17]. The DNA
isolated from the Salmonella enterica serovar Braenderup strain
H9812 and restricted with XbaI (Roche Diagnostics) served as the
molecular standard [23].
For the treatment with S1 nuclease, single slices of some agarose
plugs were washed twice in S1 nuclease buffer (50 mM NaCl,
30 mM sodium acetate [pH 4.5], 5 mM ZnSO4) and incubated
with 1 unit of Aspergillus oryzae S1 nuclease (MBI Fermentas,
Vilnius, Lithuania) in 200 ml of S1 buffer for 10 min at 37uC.
PFGE of undigested or S1-digested DNA was carried out in a
contour-clamped homogeneous electric field apparatus (CHEF
Mapper apparatus, BioRad Laboratories, Hercules, CA). A
constant temperature of 14uC was used, and the electrophoresis
parameters were as follows: voltage of 6 V/cm, an angle of 120,
and switch times of 4 to 40 sec (linear ramping factor), for 22 h.
Gels were stained with ethidium bromide and visualized in a
GelDoc 2000 apparatus (Bio-Rad Laboratories).
Probes preparation and Southern hybridization
A 592 bp fragment of the bont/B gene and a 268 bp fragment of
the bont/A gene were PCR labeled with digoxigenin (DIG), using
primers described elsewhere [10] and a non-radioactive DNA
probe labeling kit (PCR DIG Probe Synthesis Kit, Roche
Diagnostics GmbH, Mannheim, Germany). The DNA was
transferred from PFGE gels to positively charged nylon mem-
branes (Hybond-N+, Roche) by overnight capillary transfer with
buffer 206 SSC (3.0 M sodium chloride, 0.3 M sodium citrate,
pH 7.0). After transfer, nylon membranes were hybridized with
either bont/B or bont/A gene probes at 42uC for 18 h in a DIG
Hyb Solution (Roche).
A chemiluminescence-based method was used to detect probe-
target hybrids, according to the manufacturer’s instructions
(Roche). Briefly, the membranes were blocked for 30 min; 20 ml
of anti-digoxigenin-AP Fab-fragments (15 U/20 ml) (Roche) were
added to the blocking solution; and the membranes were
incubated for 30 min at room temperature. After equilibration
in detection buffer, the membranes were incubated with
chemiluminescent substrate CSPD in a Hypercassette (Amersham
Pharmacia Biotech, Milan, Italy) and exposed to CL-XPosure film
(Pierce Chemical, Rockford, IL).
For membrane stripping and rehybridization, a previously
hybridized membrane was rinsed with distilled water and then
soaked three times for 30 min in 0.2 M NaOH containing 0.1%
sodium dodecyl sulfate at 37uC, to remove the bound probe. The
membrane was washed for 15 min in 26SSC and then hybridized
with a second probe.
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